Učitavanje...
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still conce...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2018
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516871/ https://ncbi.nlm.nih.gov/pubmed/30560579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|